Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.
LONDON, Jan. 22, 2025 (GLOBE NEWSWIRE) -- LinkGevity, an AI-driven drug discovery company focused on age-related diseases and ...
Dermal filler-induced alopecia is a rare yet significant complication arising from aesthetic procedures, primarily linked to ...
Mostly seen on the East Coast in places like Philadelphia, xylazine was created to be used in veterinary offices as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback